These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17911571)

  • 1. Commentary. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease. Results of ten years of prospective surveillance.
    Moneta GL
    Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):341-2. PubMed ID: 17911571
    [No Abstract]   [Full Text] [Related]  

  • 2. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M; Thombs B; Baron M;
    Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can people with Raynaud's phenomenon travel to high altitude?
    Luks AM; Grissom CK; Jean D; Swenson ER
    Wilderness Environ Med; 2009; 20(2):129-38. PubMed ID: 19594214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon of the nipples: an elusive diagnosis.
    Morino C; Winn SM
    J Hum Lact; 2007 May; 23(2):191-3. PubMed ID: 17478872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon.
    Walton A
    J Bodyw Mov Ther; 2008 Jul; 12(3):274-80. PubMed ID: 19083682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Definition and terminology of Raynaud's syndrome].
    Heidrich H
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1742-4. PubMed ID: 18696408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial scleroderma: nature, nurture or both?
    Englert H; Roberts-Thomson PJ; Byth K; Manolios N
    Intern Med J; 2008 Apr; 38(4):235-42. PubMed ID: 18298553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient renal dysfunction with Raynaud's phenomenon: is there a connection?
    Parekh S; Iyer R; Sequeira W
    J Clin Rheumatol; 2003 Apr; 9(2):88-91. PubMed ID: 17041436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve conduction velocities in the lower extremity in patients with Raynaud's phenomenon and clinical applications.
    Kostopoulos D; Rizopoulos K; Vartholomeos N
    J Bodyw Mov Ther; 2008 Jan; 12(1):58-66. PubMed ID: 19083656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
    Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM
    Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
    Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
    Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nailfold capillaroscopy in the evaluation of Raynaud's phenomenon and undifferentiated connective tissue disease].
    Cortes S; Clemente-Coelho P
    Acta Reumatol Port; 2008; 33(2):203-9. PubMed ID: 18604184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.